The launch of the Catalyst® Pancreatic Lipase Test demonstrates IDEXX's Technology for Life strategy and will provide veterinarians with quantitative results at the point-of-care in less than 10 ...
WESTBROOK, Maine, Jan. 13, 2014 /PRNewswire/ -- IDEXX Laboratories, Inc. announces a significant new addition to its leading line of point-of-care instruments, the Catalyst One(TM) Chemistry Analyzer.
Addison's disease, often called "the great pretender," is a life-threatening condition caused by low cortisol and is difficult to diagnose due to its common and nonspecific clinical signs that can ...
IDEXX Laboratories, Inc.IDXX has announced the commercial launch of its Catalyst SDMA Test to all North American customers, scheduled on Jan 16, 2018. With this, IDEXX's point-of-care customers will ...
The Catalyst ® Cortisol Test provides veterinarians with real-time critical insights when evaluating dogs for Addison's disease and Cushing's syndrome WESTBROOK, Maine, June 5, 2025 /PRNewswire/ -- ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback